Literature DB >> 7063116

Adhesive arachnoiditis in patients with spinal block.

I O Skalpe, O Sortland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7063116     DOI： 10.1007/bf00342071

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


× No keyword cloud information.
  6 in total

1.  [Arachnitis spinalis; studies on its pathogenesis with special reference to the processes in the caudal area].

Authors:  H KUHLENDAHL; H FELTEN
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1952

2.  Leptomeningeal changes following lumbar myelography with water-soluble contrast media (meglumine iothalamate and methiodal sodium).

Authors:  H Halaburt; J Lester
Journal:  Neuroradiology       Date:  1973-04       Impact factor: 2.804

3.  Thoracic myelography with metrizamide. Technical and diagnostic aspects.

Authors:  I O Skalpe; O Sortland
Journal:  Acta Radiol Suppl       Date:  1977

4.  Cauda equina arachnoiditis. A correlative clinical and roentgenologic study.

Authors:  A E Brodsky
Journal:  Spine (Phila Pa 1976)       Date:  1978-03       Impact factor: 3.468

Review 5.  Adverse effects of water-soluble contrast media in myelography, cisternography and ventriculography. A review with special reference to metrizamide.

Authors:  I O Skalpe
Journal:  Acta Radiol Suppl       Date:  1977

6.  Adhesive arachnoiditis following lumbar radiculography with water-soluble contrast agents. A clinical report with special reference to metrizamide.

Authors:  I O Skalpe
Journal:  Radiology       Date:  1976-12       Impact factor: 11.105
  6 in total
  1 in total

Review 1.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.